| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00046 | 1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.00067 | 1 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.00047 | 1 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.00049 | 1 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.00037 | 1 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.00034 | 1 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.00028 | 1 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.00024 | 1 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.00028 | 1 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.00018 | 1 |